Youwei Zhu

593 total citations
17 papers, 279 citations indexed

About

Youwei Zhu is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Youwei Zhu has authored 17 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Cancer Research and 5 papers in Molecular Biology. Recurrent topics in Youwei Zhu's work include Pancreatic and Hepatic Oncology Research (6 papers), Epigenetics and DNA Methylation (3 papers) and MicroRNA in disease regulation (3 papers). Youwei Zhu is often cited by papers focused on Pancreatic and Hepatic Oncology Research (6 papers), Epigenetics and DNA Methylation (3 papers) and MicroRNA in disease regulation (3 papers). Youwei Zhu collaborates with scholars based in China, United States and Germany. Youwei Zhu's co-authors include Hao Chen, Minmin Shi, Yiming Zhong, Chenghong Peng, Jian Wu, Baiyong Shen, Gang Wei, Xuelong Wang, Hongzhe Li and Yang Ma and has published in prestigious journals such as Frontiers in Immunology, Biochemical Pharmacology and Journal of Dental Research.

In The Last Decade

Youwei Zhu

15 papers receiving 275 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Youwei Zhu China 8 192 127 82 48 27 17 279
Banglun Pan China 10 153 0.8× 102 0.8× 73 0.9× 91 1.9× 37 1.4× 24 270
Erik Lizárraga-Verdugo Mexico 7 185 1.0× 156 1.2× 72 0.9× 23 0.5× 27 1.0× 16 291
Yuntian Hong China 10 200 1.0× 127 1.0× 63 0.8× 41 0.9× 39 1.4× 25 303
Roger Kai Cheong Ngan Hong Kong 7 164 0.9× 78 0.6× 96 1.2× 34 0.7× 18 0.7× 9 252
Joshua Victor United States 4 260 1.4× 155 1.2× 37 0.5× 25 0.5× 21 0.8× 4 314
Liying Zhang China 10 165 0.9× 98 0.8× 50 0.6× 91 1.9× 13 0.5× 22 295
Hongfei Yu China 7 245 1.3× 227 1.8× 47 0.6× 39 0.8× 33 1.2× 11 321
Jianlin Ma China 9 251 1.3× 138 1.1× 49 0.6× 65 1.4× 23 0.9× 14 306
Xuezhen Ma China 9 187 1.0× 89 0.7× 73 0.9× 33 0.7× 24 0.9× 24 274
Angela Yu United States 6 286 1.5× 197 1.6× 71 0.9× 42 0.9× 18 0.7× 6 366

Countries citing papers authored by Youwei Zhu

Since Specialization
Citations

This map shows the geographic impact of Youwei Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youwei Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youwei Zhu more than expected).

Fields of papers citing papers by Youwei Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youwei Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youwei Zhu. The network helps show where Youwei Zhu may publish in the future.

Co-authorship network of co-authors of Youwei Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Youwei Zhu. A scholar is included among the top collaborators of Youwei Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youwei Zhu. Youwei Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Zhu, Youwei, Shujuan Chen, Jianlong Li, et al.. (2025). Emergence of tigecycline-resistant Escherichia coli from swine feces and fertilized soil. Ecotoxicology and Environmental Safety. 304. 119136–119136. 1 indexed citations
2.
Li, Yiming, et al.. (2025). Factors Influencing and Methods for Improving the Storage Stability of Modified Asphalt with High SBS Content. Journal of Materials in Civil Engineering. 37(8). 1 indexed citations
3.
Shi, Minmin, Zhichong Wu, Meilin Xue, et al.. (2023). LIPH contributes to glycolytic phenotype in pancreatic ductal adenocarcinoma by activating LPA/LPAR axis and maintaining ALDOA stability. Journal of Translational Medicine. 21(1). 838–838. 10 indexed citations
4.
Jiang, Yongsheng, Lijie Han, Jian Yang, et al.. (2023). Identification of a novel immune checkpoint molecule V-set immunoglobulin domain-containing 4 that leads to impaired immunity infiltration in pancreatic ductal adenocarcinoma. Cancer Immunology Immunotherapy. 72(8). 2701–2716. 5 indexed citations
5.
Ji, Hao, Taihua Yang, Chunlai Li, et al.. (2023). EBV-encoded miRNAs BHRF1-1 and BART2-5p aggravate post- transplant lymphoproliferative disorder via LZTS2-PI3K-AKT axis. Biochemical Pharmacology. 214. 115676–115676.
6.
Yang, Liu, Yizhi Cao, Pengyi Liu, et al.. (2023). ATF3-induced activation of NF-κB pathway results in acquired PARP inhibitor resistance in pancreatic adenocarcinoma. Cellular Oncology. 47(3). 939–950. 6 indexed citations
7.
Wang, Xuelong, Youwei Zhu, Yizhi Cao, et al.. (2022). The CTCF/LncRNA‐PACERR complex recruits E1A binding protein p300 to induce pro‐tumour macrophages in pancreatic ductal adenocarcinoma via directly regulating PTGS2 expression. Clinical and Translational Medicine. 12(2). e654–e654. 32 indexed citations
8.
Zhou, Lu‐Jun, et al.. (2022). Oral Pathobionts Promote MS-like Symptoms in Mice. Journal of Dental Research. 102(2). 217–226. 11 indexed citations
9.
Jiang, Yongsheng, Lijie Han, Meilin Xue, et al.. (2022). Cystatin B increases autophagic flux by sustaining proteolytic activity of cathepsin B and fuels glycolysis in pancreatic cancer: CSTB orchestrates autophagy and glycolysis in PDAC. Clinical and Translational Medicine. 12(12). e1126–e1126. 7 indexed citations
10.
Zhu, Youwei, Zhaoyang Zhang, Jia Song, et al.. (2021). SARS-CoV-2-Encoded MiRNAs Inhibit Host Type I Interferon Pathway and Mediate Allelic Differential Expression of Susceptible Gene. Frontiers in Immunology. 12. 767726–767726. 18 indexed citations
11.
Zhu, Youwei, Meilin Xue, Yongsheng Jiang, et al.. (2021). Tumor-associated macrophages promote pancreatic ductal adenocarcinoma progression by inducing epithelial-to-mesenchymal transition. Aging. 13(3). 3386–3404. 32 indexed citations
12.
Zhu, Youwei, Meilin Xue, Yongsheng Jiang, et al.. (2020). Mycophenolate mofetil preconditioning protects mouse liver against ischemia/reperfusion injury in wild type and toll-like receptor 4 knockout mice. Transplant Immunology. 65. 101357–101357. 2 indexed citations
13.
Gu, Jiangning, Zhiwei Xu, Yang Ma, et al.. (2020). Surgical resection of metastatic pancreatic cancer: is it worth it?—a 15-year experience at a single Chinese center. Journal of Gastrointestinal Oncology. 11(2). 319–328. 8 indexed citations
14.
Gu, Jiangning, Wei Xu, Chenghong Peng, et al.. (2019). Perineural invasion is related to p38 mitogen‐activated protein kinase pathway activation and promotes tumor growth and chemoresistance in pancreatic cancer. Journal of Cellular Biochemistry. 120(7). 11775–11783. 4 indexed citations
15.
Wu, Jian, Hongzhe Li, Minmin Shi, et al.. (2019). TET1-mediated DNA hydroxymethylation activates inhibitors of the Wnt/β-catenin signaling pathway to suppress EMT in pancreatic tumor cells. Journal of Experimental & Clinical Cancer Research. 38(1). 348–348. 59 indexed citations
16.
Zhong, Yiming, Youwei Zhu, Wei Zhou, et al.. (2019). Identification of Key Transcription Factors AP-1 and AP-1-Dependent miRNAs Forming a Co-Regulatory Network Controlling PTEN in Liver Ischemia/Reperfusion Injury. BioMed Research International. 2019. 1–11. 3 indexed citations
17.
Zhu, Youwei, Jiangning Gu, Ying Li, et al.. (2017). MiR-17-5p enhances pancreatic cancer proliferation by altering cell cycle profiles via disruption of RBL2/E2F4-repressing complexes. Cancer Letters. 412. 59–68. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Banglun Pan Breakdown of academic impact, for papers by Erik Lizárraga-Verdugo Breakdown of academic impact, for papers by Yuntian Hong Breakdown of academic impact, for papers by Roger Kai Cheong Ngan Breakdown of academic impact, for papers by Joshua Victor Breakdown of academic impact, for papers by Liying Zhang Breakdown of academic impact, for papers by Hongfei Yu Breakdown of academic impact, for papers by Jianlin Ma Breakdown of academic impact, for papers by Xuezhen Ma Breakdown of academic impact, for papers by Angela Yu
Rankless by CCL
2026